Dipeptidyl peptidase-4 inhibitors and HbA1c target of<7% in type 2 diabetes: Meta-analysis of randomized controlled trials - Esposito, K; Cozzolino, D; Bellastella, G (Diabetes Obes Metab, 2011)
et al.